Dr Andrea Luk is an endocrinologist and is currently Professor of the Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong. She is also the Director of the CUHK Clinical Research Management Office, Medical Director (non-oncology) of the CUHK Phase 1 Clinical Trial Centre, and serves as an Honorary Consultant at the Prince of Wales Hospital. Dr Luk’s research interests include diabetes epidemiology, young-onset diabetes, and translational research related to diabetes care paths. Dr Luk leads the analysis of a large database of 1 million people with diabetes in Hong Kong. She has published over 230 articles in peer reviewed journals.

Professor Elif Ekinci is a clinician scientist, an academic endocrinologist who is working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She is the Head of Department of Medicine at the University of Melbourne and overseas the Department of Medicine activity across The University of Melbourne affiliated hospitals including Austin Health, Melbourne Health, Northern Health, Western Health and St Vincent's Health. She is also the Weary Dunlop Medical Research Foundation Professorial Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at The University of Melbourne. The Dame Kate Campbell Fellowship is given to researchers recognising incredible contributions to the University of Melbourne for outstanding research and wider involvement in our local community and across the globe. She is also the Head of Diabetes research at Austin Health, where she heads diabetes and obesity clinical trials at the Centre for Research and Education in Diabetes and Obesity. Prof Ekinci is the inaugural director of Australian Centre for Accelerating Diabetes Innovations (ACADI). ACADI will deliver novel interventions for timely diagnosis, prevention and treatment of diabetes and its complications with the access to clinical evaluation, leadership and networks, research commercialisation experience and workforce training. ACADI's design responds to key barriers slowing Australian development of innovations.

Dr Marie Sinclair is an Associate Professor at the University of Melbourne and a transplant hepatologist at Austin Health, Australia. Her research focuses on obesity, MASLD, sarcopenia, and nutrition in advanced liver disease, with extensive experience in multicentre clinical trials and translational hepatology research.

John is a clinician-scientist whose research focuses on the prediction and prevention of type 1 diabetes.

Dr Yee Wen Kong is an endocrinologist with a strong interest in type 1 diabetes and diabetes technology research. She is pursuing a PhD, focusing on ketone monitoring technology and use to SGLT2 inhibitors in type 1 diabetes.

Dr. Rama Walia is an additional professor in the Department of Endocrinology at the Postgraduate Institute of Medical Education and Research, Chandigarh. Her research focuses on endocrinology, puberty and fertility disorders, diabetes, and metabolic diseases. She has contributed extensively to clinical research and published widely in reputed international journals.